INHIBIKASE THERAPEUTICS INC (IKT)
US45719W2052 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to IKT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 17.85. This target is 739.6% above the current price.
IKT was analyzed by 6 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about IKT.
In the previous month the buy percentage consensus was at a similar level.
IKT was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-30 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-06-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-18 | HC Wainwright & Co. | Initiate | Buy |
| 2022-11-16 | JonesTrading | Downgrade | Buy -> Hold |
| 2021-07-15 | JonesTrading | Initiate | Buy |